SOURCE: LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc.

September 24, 2015 16:00 ET

LED Medical Diagnostics Announces Issuance of Senior Secured Debentures Totaling US$500,000

VANCOUVER, BC--(Marketwired - September 24, 2015) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company") announced today that it is completing the second tranche to the previously announced debenture financing as disclosed in a news release by LED on July 22, 2015. In this second tranche the Company will issue US$500,000 of 10% senior secured debentures each in the amount of US$10,000 (the "Debentures") and maturing after 12 months. The Debentures are being issued as part of a non-brokered private placement of units (each a "Unit") with each Unit consisting of: (i) a Debenture; and (ii) 7,143 common share purchase warrants of the Company (each a "Warrant"). The lender for all Debentures will be the Bloom Burton Healthcare Lending Trust. The subscription price for each Unit is US$10,000.

The Company is granting the Warrants as a loan bonus in accordance with Exchange Policy 5.1 of the TSX Venture Exchange (the "TSX-V") and each such Warrant will entitle the holder thereof to acquire one common share in the capital of the Company for USD$0.28 for a period of 12 months from the closing of the issuance of the Debentures.

The proceeds will be used by LED for general corporate purposes.

All securities issued in connection with the transaction are subject to a hold period expiring four months after the closing date.

The completion of the private placement is subject to final approval of the TSX-Venture Exchange (the “Exchange”) which will be evidenced by the issuance of the Exchange bulletin.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX-V under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 884.952.7327 or visit www.leddental.com/investor-relations.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information